Gradientech announces appointment of new Board of directors
Gradientech is proud to announce the appointment of two new members to the Gradientech Board of Directors; Dr Hilja Ibert and Dr Nedal Safwat.
Dr Hilja Ibert is currently CEO of Gentian Diagnostics and brings more than 30 years of experience from the clinical diagnostics industry at international companies like Hologic, Becton Dickinson and bioMérieux, including Vice President and General Manager positions within the business areas of Diagnostic systems and Bioscience.
Dr Nedal Safwat is currently the Vice President and Head of Molecular Diagnostics North America at Qiagen. Previous to his current position, Dr Nedal Safwat brings more than 15 years of experience from the clinical diagnostics industry, specifically with business unit and commercial roles at bioMérieux covering microbiology applications including bacteria identification, antibiotic susceptibility testing, antibiotic resistance, and sepsis detection products.
Next-generation antimicrobial susceptibility testingTake a look at our E-book